MYC-dependent recruitment of RUNX1 and GATA2 on the SET oncogene promoter enhances PP2A inactivation in acute myeloid leukemia

SUPPLEMENTARY MATERIALS AND METHODS
Cell lines culture
HL-60, HEL, and A549 cells were maintained in RPMI-1640 (Invitrogen) with 10% fetal bovine serum (Life Technologies). NIH3T3, HEK293t and HeLa cells were grown in DMEM supplemented with 10% fetal calf serum (Life Technologies). Cell lines were grown at 37°C in a 5% CO 2 atmosphere. Media were supplemented with penicillin G (100 U/mL), and streptomycin (0.1 mg/mL).
shRNA stable cells
HEK293t cells were transduced with scramble shRNA (sc-108080) and a specific SET shRNA with the following hairpin sequence: 5′-GATCCAAATAAAGTT CTCTCCAAATTCAAGAGATTTGGAGAGAACTTTA TTTTTTTT-3′, (sc-43856, both from Santa Cruz, USA). The virus-loaded supernatant obtained was used to infect AML cells. After 72h, fresh media were added to the cells and they were maintained for one week in presence of puromycin (Sigma) until the collection of the samples.
siRNA transient transfections
To knock down SET expression, three different siRNAs for SET inhibition were tested. The siRNA previously described (37) with the following sequence 5′-AAACGUUCGAGUCAAACGCAG -3′, was the most effective at the concentration of 400 pmol and was used for the experiments. For the depletion of RUNX1, GATA2, SP1 and MYC in AML cells, we used the following siRNAs: ON-TARGETplus SMARTpool siRNA L-003926-00-0005 for RUNX1 (GE Healthcare Dharmacon), GATA2 stealth 1299001 for GATA2 (Life Technologies), SP1 Santa Cruz siRNA sc-29487 (siSP1 #2) or custom designed SP1 (siSP1 #1) and MYC siRNAs with the following sequence: 5′-AAGGAGUUGGUGGCAAUAA-3′ and 5′-UCCUGAGACAGAUCAGCAACAACCG-3′ respectively. siRNA transfection was performed by electroporation with the Gene-Pulser-Xcell Electroporation System (Bio-Rad, Benicia, CA, USA) using 300 V and a capacitance of 1000 mF for HL-60; 395V and 950mF for HEL. Calcium Phosphate transfection method was used for HEK293t cells.
Cell proliferation
Cell proliferation was determined by MTS assay (Promega, USA) following the manufacturer's instructions. The cell growth curve was generated accordingly, harvesting the cells at 24h intervals during 72 or 96h.
Colony formation assay
Cells were plated in triplicate in six-well plates with agarose (Pronadisa) (top layer 0.3%; bottom layer 0.6%) and incubated until colonies were visible (10 days). The colonies were stained by adding 500 μL of 5 mg/mL MTT reagent (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, Sigma) during 4h at 37°C. Colonies were fixed by overnight incubation with DMSO at 37°C and their number was assessed using Image J software (NIH, USA).
Assessment of apoptosis by flow cytometry
Flow cytometry, after staining with Annexin V and Propidium Iodide (PI), was used to determine the level of early and late-stage apoptosis following the manufacturer's protocol (BD Biosciences). Briefly, PBS washed cells were suspended in a total volume of 100 μl binding buffer (1X) and incubated with 5 μl Annexin V and 5 μl PI during 15 min in the dark at room temperature. After this incubation, the cells were suspended to a total volume of 500 μl and analyzed with a flow cytometer (Becton Dickinson FACScalibur). Data analysis was performed with CellQuest software. For the graphical representation of apoptosis data, the sum of the percentages of early and late cell death (Annexin V positive cells) was used.
RNA retrotranscription and quantitative real time PCR (qRT-PCR)
RNA was isolated with RNeasy-Mini-Kit (Qiagen, USA) and 2 μg were used for cDNA synthesis with the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, USA). qRT-PCR was performed with 20 ng of cDNA in the ABI-Prism-7500 (Applied Biosystems, USA) using specific primers for SET and HPRT (housekeeping), as listed in the Supplementary Table S1. Values are the mean ± SD of three independent experiments. Asterisks indicate the significance between the different constructs. *P < 0.05, **P < 0.01, ***P < 0.001, Two-way ANOVA and Bonferroni post-hoc tests were used. B. Chromatin Immunoprecipitation assay assessing the fold enrichment in the binding of the analyzed TFs to the (-933/-587bp) and (-318/-144bp) regions compared with a distal genomic sequence on the same chromosome 9 used as a negative control (CTRL). qRT-PCR results were calculated using the 2-ΔΔCt method and they are presented as the fold enrichment of chromatin DNA precipitated by the specific antibody versus chromatin DNA precipitated by normal IgG. Values are the mean ± SD of two independent experiments. Statistical significant differences are indicated: *P < 0.05, **P < 0.01, ***P < 0.001. C. ChIP-re-ChIP assay performed in the HEL. Technical procedures were carried out as described in Materials and Methods. MYC antibody was used for the first immunoprecipitation, and SP1,
